Quarterly report · Q2
8095.TEDINET S100RE4A
Period2022-12-01 → 2023-05-31
Filed2023-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.9bn | 2022-12-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥208m | 2022-12-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥284m | 2022-12-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥68m | 2022-12-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥228m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥236m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥64.8bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.2bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.6bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.4bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.3bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥804m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.0bn | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥639m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.78 | 2022-12-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.55 | 2023-03-01 → 2023-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.9% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥669,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-05-31 | −¥49m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-05-31 | ¥18m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥7.8bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥559m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥84m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥8.9bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥8.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥56m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥79m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥81m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥6.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥191m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥326m |
| —segment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| —segment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥840m |
| —segment total | segment profit | 2022-12-01 → 2023-05-31 | ¥239m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥841m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-05-31 | ¥190m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 636
| Item | Context | Value | Unit |
|---|---|---|---|
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Money consumption loan agreement by syndication method (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding gain or loss on sales of non current assets (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding loss on valuation of investment securities (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding loss on revision of retirement benefit plan (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding proceeds from sales of treasury stock and purchase of treasury stock (text) | CurrentYTDDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYTDDuration | Text · Plus | |
| Major components of assets and liabilities increased or decreased as result of acquisition or disposal of business or merger etc whereby cash was paid or received as consideration (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |